Skip to main content
OpenTrials
Completed

NCT Number: NCT02434575

UK ROPE Register Study

This registry study enables us to collect data on the treatment of LUTS using prostate artery embolisation (PAE), and other surgical methods to answer the following questions posed by NICE in 2013:

* Is PAE a safe and effective treatment option for LUTS caused by prostate enlargement? * How does PAE compare with conventional surgical treatments? This will primarily be a surgical procedure called transurethral resection of the prostate (TURP) (see below). * Which patients would most benefit from PAE over the other treatment options?

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Male

Study type

Observational

Primary location

Colchester Hospital University NHS Foundation Trust, Colchester, Essex, United Kingdom

Loading trial locations.

About this study

This is a study protocol for the UK ROPE Register for Lower Urinary Tract Symptoms (LUTS). This register enables us to collect data on the treatment of LUTS using prostate artery embolisation (PAE), and other surgical methods to answer the following questions posed by NICE in 2013:

  • Is PAE a safe and effective treatment option for LUTS caused by prostate enlargement?
  • How does PAE compare with conventional surgical treatments? This will primarily be a surgical procedure called transurethral resection of the prostate (TURP) (see below).
  • Which patients would most benefit from PAE over the other treatment options? This study involves populating the UK ROPE Register with data from patients who have undergone prostate artery embolisation (PAE) and the current standard treatment in the UK, transurethral resection of the prostate (TURP). All consecutive patients receiving PAE in UK sites taking part in this study over the course of 12 months (from the date that the first patient is enrolled) will be invited to join the UK ROPE register. At least 150 PAE patients will be enrolled into this study, and a comparable number of TURP patients (at least 150 patients also) from a maximum of 18 sites in the UK. It is anticipated that each site will enrol between 10 and 30 PAE patients in 12 months. Enrolment will only continue past 12 months until 150 PAE patients have been added to the register.

NICE has suggested keeping a registry or database of patients who have undergone this procedure in the UK. so that we can find out more about how safe and effective it is for patients and how it compares to the other established treatments available such as surgery. The UK ROPE Register will be owned and hosted by the British Society of Interventional Radiologists (BSIR) and the British Association of Urological Surgeons (BAUS). The register will be built by Dendrite, a commercial company that specialise in making medical registers and databases. Cedar, a consortium of Cardiff & Vale UHB and Cardiff University and an External Assessment Centre (EAC) to NICE, was commissioned to facilitate the registry research. Cedar's role is to work with the steering group (consisting of BSIR, BAUS, and NICE representatives) to help build the ROPE Register and ensure that the right data points are collected to answer research questions for NICE. Cedar will also perform the data analysis from the ROPE Register and will publish the results in a peer-reviewed scientific journal.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men with LUTS who have consented for PAE, TURP, open prostatectomy or laser surgery at a participating site
  • Able to read, write and understand English
  • Capable of giving informed written consent

Exclusion criteria

  • Not able to read, write or understand English
  • Not able/willing to provide informed written consent

Treatment and study plan

Primary outcomes

  1. IPSS change for PAE patients, from baseline 12 months post procedure

    Time frame: 12 months

    Comparison of IPSS questionnaire score at baseline at 12 months post-PAE procedure

Secondary outcomes

  1. IPSS comparison of PAE with TURP, 12 months post-procedure

    Time frame: 12 Months

    Comparison of IPSS score changes between PAE and TURP cases, 12 months post-procedure. Non inferiority study.

  2. Safety of PAE procedure - Number of patients with adverse events up to 12 months post-procedure

    Time frame: 12 months

    Any anticipated complications of PAE should be recorded on the ROPE Register up to 12 months post-procedure. These include: Local dissection, non-target embolisation, groin haematoma, sepsis, transfusion, TUR syndrome, bladder wall injury, antibiotics needed post-PAE (implying infection), and catheterisation. Patient-reported complications include pain, haematuria, haematospermia, retrograde ejaculation, catheterisation, and hospital re-admission.

  3. IPSS comparison of other treatments (HoLEP, Open prostatectomy) to PAE, 12 months post-procedure

    Time frame: 12 months

    Descriptive statistics for comparison of PAE with other treatments (HoLEP, Open prostatectomy) using IPSS.

  4. IIEF comparison of TURP, HoLEP and Open prostatectomy to PAE, 12 months post-procedure.

    Time frame: 12 months

    Descriptive statistics for comparison of PAE with other treatments (Open Prostatectomy or laser surgery) using IIEF.

  5. Prostate volume comparison of TURP, HoLEP and Open prostatectomy to PAE, 12 months post-procedure.

    Time frame: 12 months

    Descriptive statistics for comparison of PAE with other treatments (TURP, Open Prostatectomy or HoLEP) using prostate volume.

  6. Urinary flow study comparison of TURP, HoLEP and Open prostatectomy to PAE, 12 months post-procedure.

    Time frame: 12 months

    Descriptive statistics for comparison of PAE with other treatments (TURP, Open Prostatectomy or HoLEP) using urinary flow studies.

Sponsors and collaborators

Lead sponsor

Cardiff and Vale University Health Board

Other Gov

Collaborators

  • British Association of Urological Surgeons
  • British Society of Interventional Radiologists
  • National Instutite of Health and Care Excellence

Registry information

Official study title

ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE)

Acronym: UK ROPE

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
May 5, 2015
Registry last updated
Feb 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.